« Back
Home /
LIF Antibody

LIF Antibody

Item no.	CSB-PA012928ESR2HU-50ul
Manufacturer	Cusabio
Amount	50 ul
Quantity options	100 ul 50 ul
Category	Oncology Metabolism Diabetes Glucose Homeostasis Antibodies Obesity Western Blot ELISA Primary Antibodies By Organ Skin Cancer Heart & Blood Cancer Immunostaining
Type	Antibody Polyclonal
Format	Liquid
Applications	ELISA
Specific against	Human (Homo sapiens)
Host	Rabbit
Isotype	IgG
Conjugate/Tag	Unconjugated
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	CDF antibody,Cholinergic Differentiation Factor antibody,D factor antibody,DIA antibody,Differentiation inducing factor antibody,differentiation inhibitory activity antibody,Differentiation stimulating factor antibody,Differentiation-stimulating factor antibody,Emfilermin antibody,Hepatocyte stimulating factor III antibody,HILDA antibody,Human interleukin in DA cells antibody,Leukemia inhibitory factor antibody,LIF antibody,LIF_HUMAN antibody,Melanoma derived LPL inhibitor antibody,Melanoma-derived LPL inhibitor antibody,MLPLI antibody
Similar products	LIF, HILDA, Leukemia inhibitory factor (LIF) (Differentiation-stimulating factor) (D factor) (Melanoma-derived LPL inhibitor) (MLPLI) (Emfilermin)
Available
Manufacturer - Type	Polyclonal Antibody
Manufacturer - Targets	LIF
Storage Conditions	Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Manufacturer - Alias	CDF antibody, Cholinergic Differentiation Factor antibody, D factor antibody, DIA antibody, Differentiation inducing factor antibody, differentiation inhibitory activity antibody, Differentiation stimulating factor antibody, Differentiation-stimulating factor antibody, Emfilermin antibody, Hepatocyte stimulating factor III antibody, HILDA antibody, Human interleukin in DA cells antibody, Leukemia inhibitory factor antibody, LIF antibody, LIF_HUMAN antibody, Melanoma derived LPL inhibitor antibody, Melanoma-derived LPL inhibitor antibody, MLPLI antibody
Immunogen Species	Human
Immunogen	Recombinant Human Leukemia inhibitory factor protein (23-202AA)
Background	LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.
Buffer	PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
Purification Method	Antigen Affinity Purified
General Research Areas	Immunology
Initial Research Areas	Immunology
Antigen Species	Human
Antigen	Recombinant Human Leukemia inhibitory factor protein (23-202AA)
Clonality	Polyclonal

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

CSB-PA012928ESR2HU-50ul-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 50 ul

available

Delivery expected until 12/18/2025

Compare

Add to wishlist

Get an offer

Request delivery time